Sponsor:
Axsome Therapeutics, Inc.
Code:
NCT07717879
Conditions
ADHD
Eligibility Criteria
Sex: All
Age: 6 - 11
Healthy Volunteers: Not accepted
Interventions
Solriamfetol Dose A
Solriamfetol Dose B
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-31. This information was provided to ClinicalTrials.gov by Axsome Therapeutics, Inc. on 2026-07-21.